EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Proceedings of the Clinical Microbiology Open 2022—assessing clinical laboratory and industry responses to COVID-19 pandemic testing capacity challenges (part 1)

David R Peaper iD, Christopher D Doern iD, Susan Sharp, ASM Clinical and Public Health Microbiology Committee and the ASM Corporate Council

Journal of Clinical Microbiology · 2024

DOI: 10.1128/jcm.00941-23 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of Clinical Microbiology, 2024. Verfasst von David R Peaper und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Laboratory Medicine, Yale School of Medicine, New Haven, Connecticut, USA. Hauptthemen laut MEDLINE: COVID-19. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 7 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

As the COVID-19 pandemic winds down, clinical and public health laboratories, along with industry partners, reflect on the successes and failures of the pandemic response. To capture the lessons learned and better prepare for the next pandemic, the Clinical Microbiology Open (CMO) assembled key stakeholders including directors of clinical laboratories, industry partners, and state and federal agencies such as the Centers for Disease Control and Prevention and the Food and Drug Administration. Participants were asked to provide their perspectives on the initial pandemic response, supply chain constraints especially during surges, staffing challenges, test triage and communication strategies, clinical informatics needs, laboratory financial impacts of SARS-CoV-2 testing, and the emergency use authorization process. This manuscript summarizes the diagnostic laboratory and industry perspectives on these issues that were presented and discussed at CMO and proposes some steps that could be taken to improve future pandemic responses.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

COVID-19HumansCOVID-19 TestingLaboratories, ClinicalSARS-CoV-2Pandemics

Stichwörter der Autor:innen

COVID-19pandemic

Autor:innen und Institutionen

  • Department of Laboratory Medicine, Yale School of Medicine, New Haven, Connecticut, USA.
  • Department of Pathology, Virginia Commonwealth University Health System, Richmond, Virginia, USA.
  • Herbert Wertheim College of Medicine, Florida International University, Miami, Florida, USA.
  • Copan Diagnostics, Inc., Carlsbad, California, USA.

ORCID-Profile: David R Peaper, Christopher D Doern

Zitieren

APA

Peaper, D. R., Doern, C. D., Sharp, S., & ASM Clinical and Public Health Microbiology Committee and the ASM Corporate Council (2024). Proceedings of the Clinical Microbiology Open 2022—assessing clinical laboratory and industry responses to COVID-19 pandemic testing capacity challenges (part 1). Journal of Clinical Microbiology. https://doi.org/10.1128/jcm.00941-23

Vancouver

Peaper DR, Doern CD, Sharp S, ASM Clinical and Public Health Microbiology Committee and the ASM Corporate Council. Proceedings of the Clinical Microbiology Open 2022—assessing clinical laboratory and industry responses to COVID-19 pandemic testing capacity challenges (part 1). Journal of Clinical Microbiology. 2024. doi:10.1128/jcm.00941-23

BibTeX
@article{Peaper2024,
  author = {Peaper, David R and Doern, Christopher D and Sharp, Susan and ASM Clinical and Public Health Microbiology Committee and the ASM Corporate Council, ASM Clinical and Public Health Microbiology Committee and the ASM Corporate Council},
  title = {Proceedings of the Clinical Microbiology Open 2022—assessing clinical laboratory and industry responses to COVID-19 pandemic testing capacity challenges (part 1)},
  journal = {Journal of Clinical Microbiology},
  year = {2024},
  doi = {10.1128/jcm.00941-23}
}
Kostenlos starten →